Thailand has approved the Sinopharm COVID-19 vaccine as another option for those entering the Kingdom while the Ministry of Foreign Affairs has improved its central registration system for access requests.
Director of the Department of Information and spokesperson for the Ministry of Foreign Affairs Thani Saengrat, announced today that as part of a decision to reduce the quarantine period for arrivals in Thailand, the ministry has enhanced the coethailand.mfa.go.th website, which is used by Thai and foreign travelers to request Certificate of Entry (COE) documentation. The site now features a system for inputting personal information, uploading vaccination documentation and notifies registrants of their expected quarantine time so that they may plan accordingly.
The Ministry of Public Health meanwhile has approved the Beijing Institute of Biological Products’ Sinopharm COVID-19 vaccine as another recognized inoculation, allowing recipients to observe a seven-day quarantine rather than 10 days. Those arriving from countries with new strains of the illness are still subject to a 14-day quarantine.
The eight vaccines registered in Thailand or approved by the World Health Organization are: Sinovac’s CoronaVac, AstraZeneca/Oxford’s AZD 1222, SK Bioscience’s (Korea) AZD 1222, Johnson & Johnson’s Ad26.COV2.S, Pfizer-Bioentech’s Tozinameran, Serum Institute of India’s Covishield, Moderna’s mRNA-1273 and Beijing Institute of Biological Products’ Sinopharm.